Mycotopia Therapies (TPIA) 10-K 15 Apr 21 2020 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2020	Apr. 12, 2021	Jun. 30, 2020
Details
Registrant CIK	0001763329
Fiscal Year End	--12-31
Registrant Name	20/20 GLOBAL, INC.
SEC Form	10-K
Period End date	Dec. 31, 2020
Tax Identification Number (TIN)	87-0645794
Number of common stock shares outstanding		12,925,420
Public Float			$ 56,583
Filer Category	Non-accelerated Filer
Current with reporting	Yes
Interactive Data Current	Yes
Voluntary filer	No
Well-known Seasoned Issuer	No
Shell Company	false
Small Business	true
Emerging Growth Company	false
Document Annual Report	true
Document Transition Report	false
Entity File Number	000-56022
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	18851 NE 29th Ave.
Entity Address, Address Line Two	Suite 700
Entity Address, City or Town	Aventura
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33180
Country Region	954
City Area Code	233
Local Phone Number	3511
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash	$ 22,553	$ 209,164
Deposit on acquisition of Mycotopia Therapies, Inc.	350,000	0
Prepaid expenses	0	7,606
Other deposits and receivables	48,096	50,100
Note receivable	0	1,000
Assets of discontinued operations	34,806	946,715
Total current assets	455,455	1,214,585
Property, plant, and equipment, net	0	548
TOTAL ASSETS	455,455	1,215,133
Current liabilities:
Accrued liabilities	1,149	55,967
Liabilities of discontinued operations	0	507,263
Total current liabilities	1,149	563,230
TOTAL LIABILITIES	1,149	563,230
STOCKHOLDERS' EQUITY
Preferred stock, $0.001 par value; 5,000,000 shares authorized and no shares issued or outstanding	0	0
Common stock, $0.001 par value; 100,000,000 shares authorized; 12,925,420 and 12,425,420 shares issued and outstanding, respectively	12,925	12,425
Additional paid-in capital	70,354	26,246
Retained earnings	371,027	613,232
TOTAL STOCKHOLDERS' EQUITY	454,306	651,903
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 455,455	$ 1,215,133

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets - Parenthetical - $ / shares	Dec. 31, 2020	Dec. 31, 2019
Details
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	12,925,420	12,425,420
Common Stock, Shares, Outstanding	12,925,420	12,425,420

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Details
Revenue	$ 0	$ 0
Cost of revenues	0	0
Gross profit	0	0
Operating expenses:
General and administrative expenses	134,449	251,718
Consulting - related party	25,000	0
Total operating expense	159,449	251,718
Loss from operations	(159,449)	(251,718)
Other income (expense):
Interest income	2,214	16,253
Interest expense	0	(8)
Other income	0	22,251
Loss on legal settlement	0	(40,000)
Total other income (expense)	2,214	(1,504)
Net loss before provision for income tax	(157,235)	(253,222)
Provision for income tax	0	0
Net loss from continuing operations	(157,235)	(253,222)
Net (loss) income from discontinued operations, net of tax	(84,970)	258,025
Net (loss) income	$ (242,205)	$ 4,803
Basic and fully diluted earnings per share from continuing operations	$ (0.01)	$ (0.02)
Basic and fully diluted earnings per share from discontinued operations	(0.01)	0.02
Basic and fully diluted earnings per share	$ (0.02)	$ 0
Weighed average shares outstanding - basic and diluted	12,651,447	12,425,420

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings	Total
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2018	$ 0	$ 12,425	$ 26,246	$ 608,429	$ 647,100
Shares, Outstanding, Beginning Balance at Dec. 31, 2018		12,425,420
Net (loss) income	0	$ 0	0	4,803	4,803
Stockholders' Equity Attributable to Parent, Ending Balance at Dec. 31, 2019	0	$ 12,425	26,246	613,232	651,903
Shares, Outstanding, Ending Balance at Dec. 31, 2019		12,425,420
Stock compensation - related party					0
Stock compensation					0
Net (loss) income	0	$ 0	0	(242,205)	(242,205)
Stockholders' Equity Attributable to Parent, Ending Balance at Dec. 31, 2020	0	$ 12,925	70,354	371,027	454,306
Shares, Outstanding, Ending Balance at Dec. 31, 2020		12,925,420
Stock compensation - related party	0	$ 500	24,500	0	25,000
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		500,000
Stock compensation	$ 0	$ 0	$ 19,608	$ 0	$ 19,608

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net (loss) income	$ (242,205)	$ 4,803
Less: net loss (income) from discontinued operations	84,970	(258,025)
Depreciation expense	548	323
Stock compensation - related party	25,000	0
Stock compensation	19,608	0
Change in operating assets and liabilities:
Prepaid and other receivables	9,610	1,547
Accounts payable and accrued liabilities	(54,818)	52,729
Operating cash flow from discontinued operations	(145,518)	297,290
Net cash (used in) provided by operating activities	(302,805)	98,667
Cash flows from investing activities:
Deposit on acquisition of Mycotopia Therapies, Inc.	(350,000)	0
Issuance of note receivable	0	(4,500)
Repayment of note receivable	1,000	3,500
Net cash used in investing activities	(349,000)	(1,000)
Net (decrease) increase in cash	(651,805)	97,667
Cash of continuing operations at beginning of period	209,164	0
Cash of discontinued operations at beginning of period	500,000	611,497
Cash at end of period	57,359	709,164
Less: cash of discontinued operations, end of period	(34,806)	(500,000)
Cash of continuing operations at end of period	22,553	209,164
Supplemental cash flow information:
Cash paid for interest	0	8
Cash paid for income taxes	$ 0	$ 0

NOTE 1 - ORGANIZATION AND DESCR

NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS	12 Months Ended
	Dec. 31, 2020
Notes
NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS	NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS Organization and Business Activity We were incorporated in Nevada on January 21, 2000, under the name RM Investors, Inc. On March 15, 2014, under the terms of an Exchange Agreement and Plan of Reorganization, we acquired 100% of the issued and outstanding shares of our subsidiary 20/20 Produce Sales, Inc., an Idaho corporation that was incorporated on December 22, 1994. Our business operations are conducted through our wholly owned subsidiary. In connection with this reorganization, we obtained a new CUSIP number for our common stock, FINRA approval of our name change from RM Investors, Inc. to 20/20 Global, Inc. and a new trading symbol for our shares on the OTC market place, and effected a 2-for-1 forward split of the then-issued and outstanding shares of our common stock. In December 2020, we entered into definitive agreements with Ehave, Inc., an Ontario corporation, Mycotopia Therapies Inc., a Florida corporation and wholly owned subsidiary of Ehave, Inc., and the former and current directors of 20/20 Global that provide for the 20/20 Global’s purchase of all of the outstanding stock of Mycotopia Therapies, Inc. from Ehave, Inc. (see Note 10). Since the reverse merger on January 20, 2021 (the “Closing”), the Company has been leveraging its relationship with its parent company, Ehave, Inc. (“EHVVF”) to integrate the use of digital and data therapeutics to measure the effect of Psylicibin and related compounds on mental health. Our accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern. However, we have recently been forced to discontinue our only revenue stream, which raises substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

NOTE 2 - SUMMARY OF SIGNIFICANT

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2020
Notes
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Basis of Consolidation The accompanying consolidated financial statements include the accounts of 20/20 Global, Inc. and our wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated in these consolidated financial statements. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Our financial statements include, when applicable, disclosures of estimates, assumptions, uncertainties, and markets that could affect our financial statements and future operations. Reclassifications The prior-year amounts have been modified in these financial statements to properly report amounts under current operations and discontinued operations (see Note 9). Cash and Cash Equivalents We consider all highly liquid investments with original maturities of less than three months, which are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss in value, to be cash equivalents. Accounts Receivable and Doubtful Accounts Accounts receivable are stated at invoice value, which is net of any off-invoice promotions. A provision for doubtful accounts is recorded and based upon an assessment of credit risk within the accounts receivable portfolio, experience of delinquencies and charge-offs, and current market conditions. Management believes these provisions are adequate based upon the relevant information presently available. The allowance provided for the years ended December 31, 2020 and 2019 was $0. The write-offs for the years ended December 31, 2020 and 2019, were $0 and $15,440, respectively Inventory Substantially all inventories are stated at cost at the lower of first-in, first-out (“FIFO”) method or market. Inventory consists of packaging/raw materials. Fixed Assets and Depreciation Property, plant, and equipment are stated at cost. For financial reporting, we provide for depreciation on the straight-line method at rates based upon the estimated useful lives of the various assets. Depreciation expense was $548 and $323 for the years ended December 31, 2020 and 2019, respectively. The estimated useful lives are as follows: buildings and improvements—30 years; machinery and equipment—10-15 years; computer software—3-5 years; vehicles—3-7 years; and land improvements—10-20 years. We assess our long-lived assets for impairment whenever there is an indicator of impairment. Impairment losses are evaluated if the estimated undiscounted cash flows from using the assets are less than carrying value. A loss is recognized when the carrying value of an asset exceeds its fair value. There were no impairment losses in 2020 and 2019. Revenue Recognition The Company follows Financial Accounting Standards Board (“FASB”), Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers We only apply the five-step model to contracts when it is probable that we will collect the consideration to which we are entitled in exchange for the goods or services we transfer to our customer. Once a contract is determined to be within the scope of ASC Topic 606, at contract inception we review the contract to determine which performance obligations we must deliver and which of these performance obligations are distinct. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Generally, our performance obligations are transferred to customers at a point in time, typically upon delivery. Our shipping terms typically specify FOB origination, at which time title and risk of loss, as well as shipping and handling fees, have passed on to the customer. Shipping and handling costs and fees are treated as a delivered load. On a delivered load versus an FOB load, we actually take the billing and pay the carriers. We contract with the carrier and, therefore, handle the shipping and handling charges and treat them as a “delivered sale.” Sales to our largest customer amounted to approximately 58 % % % Fair Value of Financial Instruments We follow FASB ASC subtopic 825-10-50-10, Financial Instruments-Overall-Disclosure, Fair Value Measurement-Overall-Subsequent Measurement, Subtopic 820-10-35-37 establishes a framework for measuring fair value in GAAP and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, subtopic 820-10-35-37 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by subtopic 820-10-35-37 are described below: Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data. The carrying amount of our financial assets and liabilities, such as cash, prepaid expenses, and accrued expenses approximate their fair value because of the short maturity of those instruments. Income Taxes We adopted ASC Topic 740-10-25, Income Taxes—Recognition Share-based Expenses or Stock Based Compensation We follow ASC Topic 718, Compensation–Stock Compensation, Upon the adoption of Accounting Standards Update (“ASU”) 2018-07, Compensation–Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, we Income (Loss) per Share Basic income per common share equals net income (loss) divided by weighted average common shares outstanding during the period. Diluted income (loss) per share includes the impact on dilution from all contingently issuable shares, including The computation of diluted loss per share for the year ended December 31, 2020 excludes 400,000 shares of common stock issuable under outstanding exercisable stock options. We had no potentially dilutive securities as of December 31, 2019. Recent Accounting Pronouncements We have reviewed recently issued accounting pronouncements and plan to adopt those that are applicable to us. We do not expect the adoption of any pronouncements to have an impact on our results of operations or financial position.

NOTE 3 - GOING CONCERN

NOTE 3 - GOING CONCERN	12 Months Ended
	Dec. 31, 2020
Notes
NOTE 3 - GOING CONCERN	NOTE 3 – GOING CONCERN The accompanying consolidated financial statements have been prepared on the assumption that we will continue as a going concern. As discussed in Note 1, we have discontinued our operations as of December 31, 2020. We had a net loss of loss of $157,235 from continuing operations for the year ended December 31, 2020. These factors raise substantial doubt about our ability to continue as a going concern. Our ability to continue our operations as a going concern is dependent on management’s plans, which includes successfully integrating Mycotopia Therapies, Inc. which was acquired subsequent to December 31, 2020. The financial statements do not include any adjustments that may result from the outcome of this uncertainty.

NOTE 4 - LEASE

NOTE 4 - LEASE	12 Months Ended
	Dec. 31, 2020
Notes
NOTE 4 - LEASE	NOTE 4 – LEASE On April 1, 2019, we entered into a lease agreement with Colin Gibson, director, for the lease of an automobile. The lease was considered an operating lease, required monthly payments of $350, and had a term of six years. We had accounted for the lease under ASU 842, Leases The lease expense for the year ended December 31, 2019, was $3,150, which consisted of amortization expense of $1,682 and interest expense of $1,468. The cash paid under our operating lease during the year ended December 31, 2019, was $3,150. We have used a discount rate of 8%, which is our deemed incremental borrowing rate.

NOTE 5 - RELATED-PARTY TRANSACT

NOTE 5 - RELATED-PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2020
Notes
NOTE 5 - RELATED-PARTY TRANSACTIONS	NOTE 5 – RELATED-PARTY TRANSACTIONS We lease our office from Whistling Pete Enterprises, d/b/a Legacy Center, an Idaho limited liability company. Subsequent to December 31, 2020 the lease was terminated at no cost. In accordance with ASC 842, leases, we elected to exclude short-term leases, or leases with a term of twelve months or less that do not contain a purchase option that we are reasonably certain to exercise, from our ROU asset and lease liability calculations. Whistling Pete Enterprises is owned 50% by Mark Williams, our president. Total lease payments were approximately $19,000 during the years ended December 31, 2020 and 2019, respectively. On July 20, 2020, we granted 500,000 shares of common stock to Mark Williams for consideration relating to the winding down of our operations. The shares were valued at $0.05 for total noncash expense of $25,000.

NOTE 6 - EMPLOYER IRA PLAN

NOTE 6 - EMPLOYER IRA PLAN	12 Months Ended
	Dec. 31, 2020
Notes
NOTE 6 - EMPLOYER IRA PLAN	NOTE 6 – EMPLOYER IRA PLAN In August 2014, we adopted a Premier Select Simple IRA Plan, which covers all eligible employees who choose to participate. We contribute 2% of compensation, not to exceed certain limits, for employees who participate in the IRA Plan. During the years ended December 31, 2020 and 2019, we contributed $0 and $5,256, respectively, to the IRA Plan.

NOTE 7 - INCOME TAXES

NOTE 7 - INCOME TAXES	12 Months Ended
	Dec. 31, 2020
Notes
NOTE 7 - INCOME TAXES	NOTE 7 – INCOME TAXES We recognize the financial statement effects of tax positions when it is more likely than not, based on the technical merits, that the position will be sustained upon examination by a taxing authority. Recognized tax positions are initially and subsequently measured as the largest amount of tax benefit that is more likely than not of being realized upon ultimate settlement with a taxing authority. We have not taken a tax position that, if challenged, would have a material effect on the consolidated financial statements or the effective tax rate for the years ending December 31, 2019 and 2018. We join in filing a consolidated income tax return with our subsidiary. We have allocated federal income taxes by applying 21% for the years ending December 31, 2019 and 2018, respectively, and state income taxes by applying 7.4% to our taxable income. We comply with GAAP, which requires the determination of deferred income taxes using an asset and liability approach, whereby deferred tax liabilities and assets are recognized for expected future tax consequences of temporary differences between carrying amounts and tax basis of asset and liabilities. Deferred balances are adjusted to reflect enacted changes in income tax rates. We do not have any deferred income taxes. The provision for federal and state income taxes is associated with and included in net income from discontinued operations and consists of the following components: 2020 2019 Federal $ - $ 13,093 State - 4,307 Total $ - $ 17,400 The reconciliation between income taxes at the U.S. federal and state statutory rates of approximately 28.4% and the amount recorded in the accompanying consolidated financial statements is as follows: 2020 2019 Tax expense at U.S. federal statutory rate $ (54,229) $ 13,093 Tax expense at state statutory rate (14,126) 4,307 Change in valuation allowance 68,355 - Total $ - $ 17,400 We comply with GAAP, which requires the determination of deferred income taxes using an asset and liability approach, whereby deferred tax liabilities and assets are recognized for expected future tax consequences of temporary differences between carrying amounts and tax basis of asset and liabilities. Deferred balances are adjusted to reflect enacted changes in income tax rates. Due to the likelihood that the deferred assets will not be realized, a full valuation allowance has been recorded. Deferred tax assets are as follows 2020 2019 Federal net operating loss carryforward $ 50,112 $ - State net operating loss carryforward 13,053 - Stock based compensation 5,190 - Total deferred tax assets 68,355 - Valuation allowance $ (68,355) $ - - - The company has net operating losses amounting to $238,638 for federal and Idaho which can be carried forward indefinitely but are limited to 80% usage. Each of the last three tax years we have been in operation is subject to examination by the Internal Revenue Service.

NOTE 8 - STOCKHOLDERS' EQUITY

NOTE 8 - STOCKHOLDERS' EQUITY	12 Months Ended
	Dec. 31, 2020
Notes
NOTE 8 - STOCKHOLDERS' EQUITY	NOTE 8 – STOCKHOLDERS’ EQUITY We are authorized to issue 100,000,000 shares of common stock, $0.001 par value, and 5,000,000 shares of preferred stock, $0.001 par value. Each share of common stock entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought. Stock options On November 20, 2020, the Company issued for services rendered a stock option to purchase 400,000 shares of the Company’s common stock with an exercise price of $0.001 per share and a term of one year. The option was fully vested upon grant. During the year ended December 31, 2020, the Company recorded $19,608 as general and administrative expense in the Company’s consolidated statements of operations. As of December 31, 2020 there was no unrecognized costs for options outstanding. The Company valued the options using the Black-Scholes options pricing model using the following assumptions: 1) expected term of one year, 2) expected volatility of 157%, 3) risk-free interest rate of 0.11%, and 4) dividend yield of 0%. Subsequent to the year ending December 31, 2020, the Company transferred the option to the Company’s former CEO, it was exercised, and was settled in third-party shares, in full. As of and for the year ending December 31, 2019, the Company had no stock option activity and no stock options outstanding.

NOTE 7 - DISCONTINUED OPERATION

NOTE 7 - DISCONTINUED OPERATIONS	12 Months Ended
	Dec. 31, 2020
Notes
NOTE 7 - DISCONTINUED OPERATIONS	NOTE 9 – DISCONTINUED OPERATIONS On July 1, 2019, Performance Food Group Company (“PFG”) announced that it entered into a definitive agreement to acquire Reinhart Foodservice, LLC (“Reinhart”) from Reyes Holdings, LLC. Reinhart is a principal purchaser of our fresh produce distribution business. On December 20, 2019, PFG received approval from the Federal Trade Commission to acquire Reinhart and closed the transaction on December 30, 2019. Most of our business through our License Agreement with Markon Cooperative is purchased by Reinhart. Although our Markon License Agreement has not been terminated, PFG notified us that it will use its existing suppliers, which do not include us. Since this agreement that generates over half of our existing business is effectively terminated, we decided to discontinue our fresh produce distribution business, and we have notified all of our vendors and suppliers that we will not conduct new business with them after December 27, 2019. In accordance with the provisions of ASC 205-20, Presentation of Financial Statements December 31, 2020 2019 Current Assets of Discontinued Operations: Cash $ 34,806 $ 500,000 Accounts receivable - 446,715 Inventory - - Total Current Assets of Discontinued Operations: $ 34,806 $ 946,715 Current Liabilities of Discontinued Operations: Accounts payable $ - $ 489,863 Accrual - 17,400 Total Current Liabilities of Discontinued Operations: $ - $ 507,263 In accordance with the provisions of ASC 205-20, we have not included the results of operations from discontinued operations in the results of continuing operations in the consolidated statements of operations. The results of operations from discontinued operations for the years ended December 31, 2020 and 2019, have been reflected as discontinued operations in the consolidated statements of operations for the years ended December 31, 2020 and 2019, and consist of the following. For the Year Ended December 31, 2020 2019 Revenue of discontinued operations $ - $ 12,283,783 Cost of revenues of discontinued operations - 11,612,910 Gross profit of discontinued operations - 670,873 Operating Expenses of Discontinued Operations: General and administration expenses 27,204 113,698 Business development - 42,080 Salaries and wages 57,766 212,500 Sales/marketing expense - 27,967 Taxes - payroll - 16,478 Total operating expense of discontinued operations 84,970 412,723 Operating (loss) income from discontinued operations (84,970) 258,150 Other Income of Discontinued Operations: Other income - 17,275 Net (loss) income from discontinued operations before provision for income tax (84,970) 275,425 Provision for income tax expense from discontinued operations - (17,400) Net (loss) income from discontinued operations $ (84,970) $ 258,025 In accordance with the provisions of ASC 205-20, we have included the net cash provided by discontinued operations in the consolidated statements of cash flows. The net cash provided by discontinued operations in the consolidated statements of cash flows for the years ended December 31, 2019 and 2018, consist of the following. For the Years Ended December 31, 2020 2019 Net (loss) income from discontinued operations, net of tax $ (84,970) $ 258,025 Changes in assets and liabilities: Accounts receivable 446,715 365,046 Inventory - 16,593 Accounts payable and accrued liabilities (507,263) (342,374) Net cash (used in) provided by discontinued operations $ (145,518) $ 297,290

NOTE 6 - LEGAL PROCEEDING

NOTE 6 - LEGAL PROCEEDING	12 Months Ended
	Dec. 31, 2020
Notes
NOTE 6 - LEGAL PROCEEDING	NOTE 10 – LEGAL PROCEEDINGS On June 27, 2019, the Company was served with Petitioner’s Motion to Join 20/20 Global as a Necessary Third-Party Respondent to the Present Action, and to Enforce the Judgment Entered October 9, 2018, by Ordering 20/20 Global, Inc., to Turn Over Marital Securities Earned by Respondent and Awarded to Petitioner and a Subpoena for Deposition (Records only) in the matter of In re the Marriage of Penni Gruenberg v. Myron Gruenberg, Case No. 17 D 3662, pending in the Circuit Court of Cook County, Illinois. Petitioner sought return of the shares originally represented by certificates nos. 539 and 540, which were returned by Mr. Gruenberg and cancelled by us after termination of our agreement with him for his failure to perform under the Master Services Agreement. We did not believe Mr. Gruenberg is entitled to the shares and, therefore, they could not be awarded to his spouse in litigation and vigorously defended this position. On March 6, 2020, an agreed order was entered whereby Penni Gruenberg voluntarily withdrew her petition in accordance with the terms of the settlement agreement dated March 4, 2020. Per the terms of the settlement, we paid $40,000 to Ms. Gruenberg which was recorded as loss on legal settlement as an other expense in the Company’s consolidated statements of operations for the year ending December 31, 2019.

NOTE 11 - SUBSEQUENT EVENTS

NOTE 11 - SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2020
Notes
NOTE 11 - SUBSEQUENT EVENTS	NOTE 11 – SUBSEQUENT EVENTS In December 2020, we entered into definitive agreements with Ehave, Inc., an Ontario corporation (“Ehave”), Mycotopia Therapies Inc., a Florida corporation and wholly owned subsidiary of Ehave (“MYC”), and the former and current directors of 20/20 Global that provide for: (i) 20/20 Global’s purchase for $350,000 in cash of all of the outstanding stock of MYC from Ehave under a Stock Purchase Agreement, resulting in MYC becoming a wholly owned subsidiary of 20/20 Global; and (ii) the change of control of 20/20 Global’s board of directors and management under a Change of Control and Funding Agreement. In a related transaction, Ehave agreed to purchase 9,793,754 shares of 20/20 Global common stock, which constitute approximately 75.77% of the issued and outstanding shares of 20/20 Global’s common stock, for $350,000 in cash through a Stock Purchase Agreement (“MYC SPA”) with 20/20 Global stockholders Mark D. Williams, Colin Gibson, and The Robert and Joanna Williams Trust. Prior to these transactions, neither 20/20 Global nor its officers and directors had a material relationship with Ehave, MYC, or their respective officers and directors. All of the above transactions were closed on January 19, 2021. As a result of the MYC SPA, MYC became a wholly owned subsidiary of 20/20 Global, through which we plan to conduct our operations. MYC is a start-up enterprise that proposes to develop a business to provide psychedelic-enhanced holistic methodologies to improve mental wellbeing. In the next five years, our business model will focus on the following areas: palliative care, depression, and anxiety. We will leverage our minority equity interest in PsychedeliTech Inc. and our relationship with Ehave Inc. to create new opportunities for our shareholders and partners. We hope to license and acquire access to technology and companies that will build added value for our company as this industry matures. The following table provides unaudited pro forma results for the years ended December 31, 2020 and 2019, as if the Stock Purchase Agreement consummated on January 1, 2019. The pro forma results of operations for these periods ended were prepared for comparative purposes only and do not purport to be indicative of what would have occurred had the Stock Purchase Agreement been made as of January 1, 2019 or results that may occur in the future. Pro Forma (Unaudited) for the years ended December 31, 2020 2019 Net revenue $ - $ - Net loss $ (14,253) $ (-) Net loss per common share, basic and diluted $ (0.00) $ (-) Management has evaluated subsequent events pursuant to the requirements of ASC Topic 855, Subsequent Events, from the balance sheet date through the date the financial statements were issued and has determined that no additional material subsequent events exist.

NOTE 2 - SUMMARY OF SIGNIFICA_2

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Basis of Presentation (Policies)	12 Months Ended
	Dec. 31, 2020
Policies
Basis of Presentation	Basis of Presentation Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

NOTE 2 - SUMMARY OF SIGNIFICA_3

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Basis of Consolidation (Policies)	12 Months Ended
	Dec. 31, 2020
Policies
Basis of Consolidation	Basis of Consolidation The accompanying consolidated financial statements include the accounts of 20/20 Global, Inc. and our wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated in these consolidated financial statements.

NOTE 2 - SUMMARY OF SIGNIFICA_4

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Use of Estimates (Policies)	12 Months Ended
	Dec. 31, 2020
Policies
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Our financial statements include, when applicable, disclosures of estimates, assumptions, uncertainties, and markets that could affect our financial statements and future operations.

NOTE 2 - SUMMARY OF SIGNIFICA_5

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Reclassifications (Policies)	12 Months Ended
	Dec. 31, 2020
Policies
Reclassifications	Reclassifications The prior-year amounts have been modified in these financial statements to properly report amounts under current operations and discontinued operations (see Note 9).

NOTE 2 - SUMMARY OF SIGNIFICA_6

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Cash and Cash Equivalents (Policies)	12 Months Ended
	Dec. 31, 2020
Policies
Cash and Cash Equivalents	Cash and Cash Equivalents We consider all highly liquid investments with original maturities of less than three months, which are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss in value, to be cash equivalents.

NOTE 2 - SUMMARY OF SIGNIFICA_7

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Accounts Receivable and Doubtful Accounts (Policies)	12 Months Ended
	Dec. 31, 2020
Policies
Accounts Receivable and Doubtful Accounts	Accounts Receivable and Doubtful Accounts Accounts receivable are stated at invoice value, which is net of any off-invoice promotions. A provision for doubtful accounts is recorded and based upon an assessment of credit risk within the accounts receivable portfolio, experience of delinquencies and charge-offs, and current market conditions. Management believes these provisions are adequate based upon the relevant information presently available. The allowance provided for the years ended December 31, 2020 and 2019 was $0. The write-offs for the years ended December 31, 2020 and 2019, were $0 and $15,440, respectively

NOTE 2 - SUMMARY OF SIGNIFICA_8

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Inventory (Policies)	12 Months Ended
	Dec. 31, 2020
Policies
Inventory	Inventory Substantially all inventories are stated at cost at the lower of first-in, first-out (“FIFO”) method or market. Inventory consists of packaging/raw materials.

NOTE 2 - SUMMARY OF SIGNIFICA_9

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Fixed Assets and Depreciation (Policies)	12 Months Ended
	Dec. 31, 2020
Policies
Fixed Assets and Depreciation	Fixed Assets and Depreciation Property, plant, and equipment are stated at cost. For financial reporting, we provide for depreciation on the straight-line method at rates based upon the estimated useful lives of the various assets. Depreciation expense was $548 and $323 for the years ended December 31, 2020 and 2019, respectively. The estimated useful lives are as follows: buildings and improvements—30 years; machinery and equipment—10-15 years; computer software—3-5 years; vehicles—3-7 years; and land improvements—10-20 years. We assess our long-lived assets for impairment whenever there is an indicator of impairment. Impairment losses are evaluated if the estimated undiscounted cash flows from using the assets are less than carrying value. A loss is recognized when the carrying value of an asset exceeds its fair value. There were no impairment losses in 2020 and 2019.

NOTE 2 - SUMMARY OF SIGNIFIC_10

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Revenue Recognition (Policies)	12 Months Ended
	Dec. 31, 2020
Policies
Revenue Recognition	Revenue Recognition The Company follows Financial Accounting Standards Board (“FASB”), Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers We only apply the five-step model to contracts when it is probable that we will collect the consideration to which we are entitled in exchange for the goods or services we transfer to our customer. Once a contract is determined to be within the scope of ASC Topic 606, at contract inception we review the contract to determine which performance obligations we must deliver and which of these performance obligations are distinct. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when the performance obligation is satisfied or as it is satisfied. Generally, our performance obligations are transferred to customers at a point in time, typically upon delivery. Our shipping terms typically specify FOB origination, at which time title and risk of loss, as well as shipping and handling fees, have passed on to the customer. Shipping and handling costs and fees are treated as a delivered load. On a delivered load versus an FOB load, we actually take the billing and pay the carriers. We contract with the carrier and, therefore, handle the shipping and handling charges and treat them as a “delivered sale.” Sales to our largest customer amounted to approximately 58 % % %

NOTE 2 - SUMMARY OF SIGNIFIC_11

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Fair Value of Financial Instruments (Policies)	12 Months Ended
	Dec. 31, 2020
Policies
Fair Value of Financial Instruments	Fair Value of Financial Instruments We follow FASB ASC subtopic 825-10-50-10, Financial Instruments-Overall-Disclosure, Fair Value Measurement-Overall-Subsequent Measurement, Subtopic 820-10-35-37 establishes a framework for measuring fair value in GAAP and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, subtopic 820-10-35-37 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by subtopic 820-10-35-37 are described below: Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data. The carrying amount of our financial assets and liabilities, such as cash, prepaid expenses, and accrued expenses approximate their fair value because of the short maturity of those instruments.

NOTE 2 - SUMMARY OF SIGNIFIC_12

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Income Taxes (Policies)	12 Months Ended
	Dec. 31, 2020
Policies
Income Taxes	Income Taxes We adopted ASC Topic 740-10-25, Income Taxes—Recognition

NOTE 2 - SUMMARY OF SIGNIFIC_13

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Share-based Expenses or Stock Based Compensation (Policies)	12 Months Ended
	Dec. 31, 2020
Policies
Share-based Expenses or Stock Based Compensation	Share-based Expenses or Stock Based Compensation We follow ASC Topic 718, Compensation–Stock Compensation, Upon the adoption of Accounting Standards Update (“ASU”) 2018-07, Compensation–Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, we

NOTE 2 - SUMMARY OF SIGNIFIC_14

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Income (Loss) per Share (Policies)	12 Months Ended
	Dec. 31, 2020
Policies
Income (Loss) per Share	Income (Loss) per Share Basic income per common share equals net income (loss) divided by weighted average common shares outstanding during the period. Diluted income (loss) per share includes the impact on dilution from all contingently issuable shares, including The computation of diluted loss per share for the year ended December 31, 2020 excludes 400,000 shares of common stock issuable under outstanding exercisable stock options. We had no potentially dilutive securities as of December 31, 2019.

NOTE 2 - SUMMARY OF SIGNIFIC_15

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Recent Accounting Pronouncements (Policies)	12 Months Ended
	Dec. 31, 2020
Policies
Recent Accounting Pronouncements	Recent Accounting Pronouncements We have reviewed recently issued accounting pronouncements and plan to adopt those that are applicable to us. We do not expect the adoption of any pronouncements to have an impact on our results of operations or financial position.

NOTE 7 - INCOME TAXES_ Schedule

NOTE 7 - INCOME TAXES: Schedule of Income before Income Tax (Tables)	12 Months Ended
	Dec. 31, 2020
Tables/Schedules
Schedule of Income before Income Tax	The provision for federal and state income taxes is associated with and included in net income from discontinued operations and consists of the following components: 2020 2019 Federal $ - $ 13,093 State - 4,307 Total $ - $ 17,400

NOTE 7 - INCOME TAXES_ Schedu_2

NOTE 7 - INCOME TAXES: Schedule of Effective Income Tax Rate Reconciliation (Tables)	12 Months Ended
	Dec. 31, 2020
Tables/Schedules
Schedule of Effective Income Tax Rate Reconciliation	2020 2019 Tax expense at U.S. federal statutory rate $ (54,229) $ 13,093 Tax expense at state statutory rate (14,126) 4,307 Change in valuation allowance 68,355 - Total $ - $ 17,400

NOTE 7 - INCOME TAXES_ Schedu_3

NOTE 7 - INCOME TAXES: Schedule of Deferred Tax Assets and Liabilities (Tables)	12 Months Ended
	Dec. 31, 2020
Tables/Schedules
Schedule of Deferred Tax Assets and Liabilities	2020 2019 Federal net operating loss carryforward $ 50,112 $ - State net operating loss carryforward 13,053 - Stock based compensation 5,190 - Total deferred tax assets 68,355 - Valuation allowance $ (68,355) $ - - -

NOTE 7 - DISCONTINUED OPERATI_2

NOTE 7 - DISCONTINUED OPERATIONS: Schedule of Discontinued Operations - Assets (Tables)	12 Months Ended
	Dec. 31, 2020
Tables/Schedules
Schedule of Discontinued Operations - Assets	December 31, 2020 2019 Current Assets of Discontinued Operations: Cash $ 34,806 $ 500,000 Accounts receivable - 446,715 Inventory - - Total Current Assets of Discontinued Operations: $ 34,806 $ 946,715 Current Liabilities of Discontinued Operations: Accounts payable $ - $ 489,863 Accrual - 17,400 Total Current Liabilities of Discontinued Operations: $ - $ 507,263

NOTE 7 - DISCONTINUED OPERATI_3

NOTE 7 - DISCONTINUED OPERATIONS: Schedule of Discontinued Operations - Income (Tables)	12 Months Ended
	Dec. 31, 2020
Tables/Schedules
Schedule of Discontinued Operations - Income	For the Year Ended December 31, 2020 2019 Revenue of discontinued operations $ - $ 12,283,783 Cost of revenues of discontinued operations - 11,612,910 Gross profit of discontinued operations - 670,873 Operating Expenses of Discontinued Operations: General and administration expenses 27,204 113,698 Business development - 42,080 Salaries and wages 57,766 212,500 Sales/marketing expense - 27,967 Taxes - payroll - 16,478 Total operating expense of discontinued operations 84,970 412,723 Operating (loss) income from discontinued operations (84,970) 258,150 Other Income of Discontinued Operations: Other income - 17,275 Net (loss) income from discontinued operations before provision for income tax (84,970) 275,425 Provision for income tax expense from discontinued operations - (17,400) Net (loss) income from discontinued operations $ (84,970) $ 258,025

NOTE 7 - DISCONTINUED OPERATI_4

NOTE 7 - DISCONTINUED OPERATIONS: Schedule of Discontinued Operations - Cash flows (Tables)	12 Months Ended
	Dec. 31, 2020
Tables/Schedules
Schedule of Discontinued Operations - Cash flows	For the Years Ended December 31, 2020 2019 Net (loss) income from discontinued operations, net of tax $ (84,970) $ 258,025 Changes in assets and liabilities: Accounts receivable 446,715 365,046 Inventory - 16,593 Accounts payable and accrued liabilities (507,263) (342,374) Net cash (used in) provided by discontinued operations $ (145,518) $ 297,290

NOTE 1 - ORGANIZATION AND DES_2

NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details)	Mar. 15, 2014
2020 Produce Sales Inc
Equity Method Investment, Ownership Percentage	100.00%

NOTE 2 - SUMMARY OF SIGNIFIC_16

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Accounts Receivable and Doubtful Accounts (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Details
Accounts Receivable, Allowance for Credit Loss	$ 0	$ 0
Accounts Receivable, Allowance for Credit Loss, Writeoff	$ 0	$ 15,440

NOTE 2 - SUMMARY OF SIGNIFIC_17

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Fixed Assets and Depreciation (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Depreciation expense	$ 548	$ 323	$ 548	$ 323
Building and Building Improvements
Property, Plant and Equipment, Estimated Useful Lives			30 years
Machinery and Equipment
Property, Plant and Equipment, Estimated Useful Lives			10-15 years
Software and Software Development Costs
Property, Plant and Equipment, Estimated Useful Lives			3-5 years
Vehicles
Property, Plant and Equipment, Estimated Useful Lives			3-7 years
Land Improvements
Property, Plant and Equipment, Estimated Useful Lives			10-20 years

NOTE 3 - GOING CONCERN (Details

NOTE 3 - GOING CONCERN (Details) - USD ($)	3 Months Ended		12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020
Details
Net loss from continuing operations	$ 157,235	$ 253,222	$ 157,235

NOTE 4 - LEASE (Details)

NOTE 4 - LEASE (Details) - Vehicles	12 Months Ended
	Dec. 31, 2019USD ($)
Lessor, Operating Lease, Description	On April 1, 2019, we entered into a lease agreement with Colin Gibson, director, for the lease of an automobile. The lease was considered an operating lease, required monthly payments of $350, and had a term of six years
Operating Leases, Rent Expense	$ 3,150
Capital Leases, Income Statement, Amortization Expense	1,682
Interest Expense, Lessee, Assets under Capital Lease	$ 1,468

NOTE 5 - RELATED-PARTY TRANSA_2

NOTE 5 - RELATED-PARTY TRANSACTIONS (Details) - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture	500,000
Share-based Payment Arrangement, Noncash Expense	$ 25,000	$ (19,608)	$ 0
Whistling Pete Enterprises
Lessee, Finance Lease, Lease Not yet Commenced, Variable Lease Payment, Terms and Conditions		The lease, which commenced on March 2, 2009, at a rate of $1,200 per month plus utilities.
Payments for Leasing Costs		$ 19,000	$ 19,000

NOTE 6 - EMPLOYER IRA PLAN (Det

NOTE 6 - EMPLOYER IRA PLAN (Details) - Premier Select Simple IRA Plan - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Description of Postemployment Benefits	We contribute 2% of compensation, not to exceed certain limits, for employees who participate in the IRA Plan.
IRA Plan expense	$ 0	$ 5,256

NOTE 7 - INCOME TAXES_ Schedu_4

NOTE 7 - INCOME TAXES: Schedule of Income before Income Tax (Details) - USD ($)	3 Months Ended		12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Details
Federal			$ 0	$ 13,093
State			0	4,307
Total	$ 0	$ 17,400	$ 0	$ 17,400

NOTE 7 - INCOME TAXES (Details)

NOTE 7 - INCOME TAXES (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Effective Income Tax Rate Reconciliation, Percent	28.40%
Vehicles
Operating Loss Carryforwards		$ 238,638

NOTE 7 - INCOME TAXES_ Schedu_5

NOTE 7 - INCOME TAXES: Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)	3 Months Ended		12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Details
Tax expense at U.S. federal statutory rate			$ (54,229)	$ 13,093
Tax expense at state statutory rate			(14,126)	4,307
Change in valuation allowance			68,355	0
Total	$ 0	$ 0	$ 0	$ 17,400

NOTE 7 - INCOME TAXES_ Schedu_6

NOTE 7 - INCOME TAXES: Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Details
Federal net operating loss carryforward	$ 50,112	$ 0
State net operating loss carryforward	13,053	0
Stock based compensation	5,190	0
Total deferred tax assets	68,355	0
Valuation allowance	$ (68,355)	$ 0

NOTE 8 - STOCKHOLDERS' EQUITY (

NOTE 8 - STOCKHOLDERS' EQUITY (Details) - $ / shares	Dec. 31, 2020	Dec. 31, 2019
Details
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001

NOTE 7 - DISCONTINUED OPERATI_5

NOTE 7 - DISCONTINUED OPERATIONS: Schedule of Discontinued Operations - Assets (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current Assets of Discontinued Operations:
Cash	$ 34,806	$ 500,000
Accounts receivable	0	446,715
Inventory	0	0
Total Current Assets of Discontinued Operations:	34,806	946,715
Current Liabilities of Discontinued Operations
Accounts payable	0	489,863
Accrual	0	17,400
Total Current Liabilities of Discontinued Operations:	$ 0	$ 507,263

NOTE 7 - DISCONTINUED OPERATI_6

NOTE 7 - DISCONTINUED OPERATIONS: Schedule of Discontinued Operations - Income (Details) - USD ($)	3 Months Ended		12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Details
Revenue of discontinued operations	$ 0	$ 12,283,783
Cost of revenues of discontinued operations	0	11,612,910
Gross profit of discontinued operations	0	670,873
Operating Expenses of Discontinued Operations
General and administration expenses	27,204	113,698
Business development	0	42,080
Salaries and wages	57,766	212,500
Sales/marketing expense	0	27,967
Taxes - payroll	0	16,478
Total operating expense of discontinued operations	84,970	412,723
Operating income from discontinued operations	(84,970)	258,150
Other Income of Discontinued Operations
Other income	0	17,275
Net (loss) income from discontinued operations before provision for income tax	(84,970)	275,425
Provision for income tax expense from discontinued operations	0	(17,400)	$ 0	$ (17,400)
Net (loss) income from discontinued operations	$ (84,970)	$ 258,025	$ (84,970)	$ 258,025

NOTE 7 - DISCONTINUED OPERATI_7

NOTE 7 - DISCONTINUED OPERATIONS: Schedule of Discontinued Operations - Cash flows (Details) - USD ($)	3 Months Ended		12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Details
Net (loss) income from discontinued operations, net of tax	$ (84,970)	$ 258,025	$ (84,970)	$ 258,025
Changes in assets and liabilities
Accounts receivable			446,715	365,046
Inventory			0	16,593
Accounts payable and accrued liabilities			(507,263)	(342,374)
Net cash (used in) provided by discontinued operations			$ (145,518)	$ 297,290

NOTE 6 - LEGAL PROCEEDING (Deta

NOTE 6 - LEGAL PROCEEDING (Details)	12 Months Ended
	Dec. 31, 2019USD ($)
Details
Repayments of Other Debt	$ 40,000